Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
BPC-157 Read the full profile Site of action (Localized) Origin (Gastric juice fragment) Supports angiogenesis Typical research dose (200500 mcg/day) Typical frequency (12x daily) Typical cycle length (46 weeks) Subcutaneous injection WADA-banned since 2022 Studied alone (no pairing required) TB-500 Read the full profile Site of action (Systemic) Origin (Thymosin Beta-4 fragment) Supports angiogenesis Regulates actin / cell migration Typical research dose (25 mg/week) Typical frequency (23x weekly) Typical cycle length (48 weeks) Subcutaneous injection WADA-banned since 2022 Studied alone (no pairing required) Our top-rated vendor Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing no paid placements, no affiliate influence
The benefit is not hype
Better IGF-1 optimization: The GH pulses signal the liver to naturally increase IGF-1 levels without artificial spikes
They found liraglutide increased testosterone, luteinizing hormone and follicle-stimulating hormone levels, while semaglutide improved sperm morphology
Interestingly, clinical trials reported to date on the effects of tirzepatide did include obese men and women, but results were not segregated by gender 47 , thus making it difficult to anticipate whether a sex dimorphism exist in GLP1/GIP responses
